本文選題：撤稿 + 審稿人�。� 參考：《實用心腦肺血管病雜志》2017年04期

【摘要】：正2017年4月20日,學術(shù)出版商Springer Nature發(fā)表聲明,撤下其旗下雜志Tumor Biol已發(fā)表的107篇研究,而這些研究均來自中國。此次的撤稿原因為這些論文涉嫌偽造同行評審,作者推薦審稿人時使用了審稿人的真實姓名,通過假冒審稿人的真實郵件提供積極、贊許的審稿意見而使文章得以發(fā)表。此事鬧得沸沸揚揚,甚囂塵上�？唇袢瞬恍�,思先賢教誨。清·葉天士《臨證指南醫(yī)案·華序》有言,"良醫(yī)處世,不矜名,不計利,此其立德也;挽回造化,立起沉疴,此其立功也;闡發(fā)蘊奧,聿著方書,此其立言也。一藝而三善
[Abstract]:On April 20, 2017, academic publisher Springer Nature issued a statement withdrawing 107 studies published in its Tumor Biol magazine, all from China. The reason for this withdrawal is that these papers are suspected of falsifying peer reviews. The authors recommended the reviewers by using the real name of the reviewers, providing positive and approvingly approved opinions for publication by impersonating the true emails of the reviewers. There was a great deal of uproar about the matter. Look at people today, think of the teachings of the sages. In the Qing Dynasty, Ye Tianshi's "Clinical Guide to Medical cases" has a saying, "good doctors treat the world with no pride in fame, no consideration for profit, this is also the establishment of virtue; to save the creation, to set up a serious disease, this is also the meritorious; to elucidate the arcane, Lut Fang Shu, this also stand up the words." One skill and three good
【分類號】：+

【相似文獻】

相關期刊論文 前1條

1 王立宇;;撤稿申請[J];哈爾濱醫(yī)藥;2014年02期

，

本文編號：1794577